Misplaced Pages

Athlete's heart
Other names	Athlete's heart, Athletic bradycardia, or Exercise-induced cardiomegaly
The human heart
Specialty	Sports cardiology

Athletic heart syndrome (AHS) is a non-pathological condition commonly seen in sports medicine in which the human heart is enlarged, and the resting heart rate is lower than normal.

The athlete's heart is associated with physiological cardiac remodeling as a consequence of repetitive cardiac loading. Athlete's heart is common in athletes who routinely exercise more than an hour a day, and occurs primarily in endurance athletes, though it can occasionally arise in heavy weight trainers. The condition is generally considered benign, but may occasionally hide a serious medical condition, or may even be mistaken for one.

Signs and symptoms

Athlete's heart most often does not have any physical symptoms, although an indicator would be a consistently low resting heart rate. Athletes with AHS often do not realize they have the condition unless they undergo specific medical tests, because athlete's heart is a normal, physiological adaptation of the body to the stresses of physical conditioning and aerobic exercise. People diagnosed with athlete's heart commonly display three signs that would usually indicate a heart condition when seen in a regular person: bradycardia, cardiomegaly, and cardiac hypertrophy.

Bradycardia is a slower than normal heartbeat, at around 40–60 beats per minute. Cardiomegaly is the state of an enlarged heart, and cardiac hypertrophy the thickening of the muscular wall of the heart, specifically the left ventricle, which pumps oxygenated blood to the aorta. Especially during an intensive workout, more blood and oxygen are required to the peripheral tissues of the arms and legs in highly trained athletes' bodies. A larger heart results in higher cardiac output, which may allow it to beat more slowly at rest, as more blood is pumped out with each beat.

Another sign of athlete's heart syndrome is an S3 gallop, which can be heard through a stethoscope. This sound can be heard as the diastolic pressure of the irregularly shaped heart creates a disordered blood flow. However, if an S4 gallop is heard, the patient should be given immediate attention. An S4 gallop is a stronger and louder sound created by the heart, if diseased in any way, and is typically a sign of a serious medical condition.

Cause

Athlete's heart is a result of dynamic physical activity, such as aerobic training more than 5 hours a week rather than static training such as weightlifting. During intensive prolonged endurance or strength training, the body signals the heart to pump more blood through the body to counteract the oxygen deficit building in the skeletal muscles. Enlargement of the heart is a natural physical adaptation of the body to deal with the high pressures and large amounts of blood that can affect the heart during these periods of time. Over time, the body will increase both the chamber size of the left ventricle, and the muscle mass and wall thickness of the heart.

Cardiac output, the amount of blood that leaves the heart in a given time period (i.e. liters per minute), is proportional to both the chamber sizes of the heart and the rate at which the heart beats. With a larger left ventricle, the heart rate can decrease and still maintain a level of cardiac output necessary for the body. Therefore, athletes with AHS commonly have lower resting heart rates than nonathletes.

The heart becomes enlarged, or hypertrophic, due to intense cardiovascular workouts, creating an increase in stroke volume, an enlarged left ventricle (and right ventricle), and a decrease in resting heart rate along with irregular rhythms. The wall of the left ventricle increases in size by about 15–20% of its normal capacity. No decrease of the diastolic function of the left ventricle occurs. The athlete may also experience an irregular heartbeat and a resting pulse rate between 40 and 60 beats per minute (bradycardia).

The level of physical activity in a person determines what physiological changes the heart makes. The two types of exercise are static (strength-training) and dynamic (endurance-training). Static exercise consists of weight lifting and is mostly anaerobic, meaning the body does not rely on oxygen for performance. It also moderately increases heart rate and stroke volume (oxygen debt). Dynamic exercises include running, swimming, skiing, rowing, and cycling, which rely on oxygen from the body. This type of exercise also increases both heart rate and stroke volume of the heart. Both static and dynamic exercises involve the thickening of the left ventricular wall due to increased cardiac output, which leads to physiologic hypertrophy of the heart. Once athletes stop training, the heart returns to its normal size.

Diagnosis

Athlete's heart is usually an incidental finding during a routine screening or during tests for other medical issues. An enlarged heart can be seen at echocardiography or sometimes on a chest X-ray. Similarities at presentation between athlete's heart and clinically relevant cardiac problems may prompt electrocardiography (ECG) and exercise cardiac stress tests. The ECG can detect sinus bradycardia, a resting heart rate of fewer than 60 beats per minute. This is often accompanied by sinus arrhythmia. The pulse of a person with athlete's heart can sometimes be irregular while at rest, but usually returns to normal after exercise begins.

Regarding differential diagnosis, left ventricular hypertrophy is usually indistinguishable from athlete's heart and at ECG, but can usually be discounted in the young and fit.

It is important to distinguish between athlete's heart and hypertrophic cardiomyopathy (HCM), a serious cardiovascular disease characterized by thickening of the heart's walls, which produces a similar ECG pattern at rest. This genetic disorder is found in one of 500 Americans and is a leading cause of sudden cardiac death in young athletes (although only about 8% of all cases of sudden death are actually exercise-related). The following table shows some key distinguishing characteristics of the two conditions.

Athlete's heart should not be confused with bradycardia that occurs secondary to relative energy deficiency in sport or anorexia nervosa, which involve slowing of metabolic rate and sometimes shrinkage of the heart muscle and reduced heart volume.

The medical history of the patient (endurance sports) and physical examination (bradycardia, and maybe a third or fourth heart sound), can give important hints.

• ECG – typical findings in resting position are, for example, sinus bradycardia, atrioventricular block (primary and secondary) and incomplete (IRBBB) or complete right bundle branch block (RBBB) – all those findings normalize during exercise.
• Echocardiography – differentiation between physiological and pathological increases of the heart's size is possible, especially by estimating the mass of the wall (not over 130 g/m) and its end diastolic diameter (not much less 60 mm) of the left ventricle.
• X-ray examination of the chest may show increased heart size (mimicking other possible causes of enlargement).
• Cardiac MRI - In athlete's heart, there is balanced atrioventricular remodeling, reduced thickening of the heart after detraining, no late gadolinium enhancement, low to normal T1 signal, and normal extracellular volume.

Screening related conditions

Because of several well-known and high-profile cases of athletes experiencing sudden unexpected death due to cardiac arrest, such as Reggie White and Marc-Vivien Foé, a growing movement is making an effort to have both professional and school-based athletes screened for cardiac and other related conditions, usually through a careful medical and health history, a good family history, a comprehensive physical examination including auscultation of heart and lung sounds and recording of vital signs such as heart rate and blood pressure, and increasingly, for better efforts at detection, such as an electrocardiogram.

An electrocardiogram (ECG) is a relatively straightforward procedure to administer and interpret, compared to more invasive or sophisticated tests; it can reveal or hint at many circulatory disorders and arrhythmias. Part of the cost of an ECG may be covered by some insurance companies, though routine use of ECGs or other similar procedures such as echocardiography (ECHO) are still not considered routine in these contexts. Widespread routine ECGs for all potential athletes during initial screening and then during the yearly physical assessment could well be too expensive to implement on a wide scale, especially in the face of the potentially very large demand. In some places, a shortage of funds, portable ECG machines, or qualified personnel to administer and interpret them (medical technicians, paramedics, nurses trained in cardiac monitoring, advanced practice nurses or nurse practitioners, physician assistants, and physicians in internal or family medicine or in some area of cardiopulmonary medicine) exist.

If sudden cardiac death occurs, it is usually because of pathological hypertrophic enlargement of the heart that went undetected or was incorrectly attributed to the benign "athletic" cases. Among the many alternative causes are episodes of isolated arrhythmias which degenerated into lethal VF and asystole, and various unnoticed, possibly asymptomatic cardiac congenital defects of the vessels, chambers, or valves of the heart. Other causes include carditis, endocarditis, myocarditis, and pericarditis whose symptoms were slight or ignored, or were asymptomatic.

The normal treatments for episodes due to the pathological look-alikes are the same mainstays for any other episode of cardiac arrest: cardiopulmonary resuscitation, defibrillation to restore normal sinus rhythm, and if initial defibrillation fails, administration of intravenous epinephrine or amiodarone. The goal is avoidance of infarction, heart failure, and/or lethal arrhythmias (ventricular tachycardia, ventricular fibrillation, asystole, or pulseless electrical activity), so ultimately to restore normal sinus rhythm.

Management

Athlete's heart is not dangerous for athletes (though if a nonathlete has symptoms of bradycardia, cardiomegaly, and cardiac hypertrophy, another illness may be present). Athlete's heart is not the cause of sudden cardiac death during or shortly after a workout, which mainly occurs due to hypertrophic cardiomyopathy and arrhythmogenic cardiomyopathy (ARVC), two genetic disorders. Although a link between intensive exercise and exercise-induced arrhythmogenic right ventricular cardiomyopathy exists.

No treatment is required for people with athletic heart syndrome; it does not pose any physical threats to the athlete, and despite some theoretical concerns that the ventricular remodeling might conceivably predispose for serious arrhythmias, no evidence has been found of any increased risk of long-term events. Athletes should see a physician and receive a clearance to be sure their symptoms are due to athlete's heart and not another heart disease, such as cardiomyopathy. If the athlete is uncomfortable with having athlete's heart or if a differential diagnosis is difficult, deconditioning from exercise for a period of three months allows the heart to return to its regular size. However, one long-term study of elite-trained athletes found that dilation of the left ventricle was only partially reversible after a long period of deconditioning. This deconditioning is often met with resistance to the accompanying lifestyle changes. The real risk attached to athlete's heart is if athletes or nonathletes simply assume they have the condition, instead of making sure they do not have a life-threatening heart illness.

History

The athlete's heart syndrome was first described in 1899 by Salomon Henschen. He compared the heart size of cross-country skiers to those who lived sedentary lives. He noticed that those who participated in competitive sports displayed symptoms of athlete's heart syndrome. Henschen believed the symptoms were a normal adjustment to exercise, and felt concern was not needed. Henschen believed that the entire heart became enlarged. He also believed athletes with AHS lived shorter lives than those who did not acquire the syndrome. Because his research occurred throughout the 19th century, technology was limited, and it became difficult to devise appropriate ways to measure the hearts of athletes. Few believed in Henschen's theory about athletes having larger hearts than those who did not participate in sports. The latter, however, in addition to Henschen's belief of an enlargement of the entire heart among athletes is in agreement with the four-chamber dilation seen with modern imaging modalities in individuals with athlete's heart.

See also

• Exercise hypertension

References

1. Graf C, Höher J (2009). Fachlexikon Sportmedizin: Bewegung, Fitness und Ernährung von A - Z. Deutscher Ärzteverlag. p. 221. ISBN 978-3-7691-1223-8.
2. Reuter P (2005). Der grosse Reuter: Springer Universalwörterbuch Medizin, Pharmakologie und Zahnmedizin. Birkhäuser Verlang. p. 1300. ISBN 3-540-25104-9.
3. ^ Beaumont A, Grace F, Richards J, Hough J, Oxborough D, Sculthorpe N (June 2017). "Left Ventricular Speckle Tracking-Derived Cardiac Strain and Cardiac Twist Mechanics in Athletes: A Systematic Review and Meta-Analysis of Controlled Studies". Sports Medicine. 47 (6): 1145–1170. doi:10.1007/s40279-016-0644-4. PMC 5432587. PMID 27889869.
4. Woolston C (17 January 2007). "Ills & Conditions – Athletic Heart Syndrome". CVS Caremark Health Information. Archived from the original on 4 August 2007. Retrieved 11 January 2012.
5. Ellison GM, Waring CD, Vicinanza C, Torella D (January 2012). "Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms". Heart. 98 (1): 5–10. doi:10.1136/heartjnl-2011-300639. PMID 21880653. S2CID 19630545.
6. ^ Moses S (2008). "Athletic Heart Syndrome". Family Practice Notebook. Archived from the original on 26 May 2008..
7. Fulghum K, Hill BG (2018). "Metabolic Mechanisms of Exercise-Induced Cardiac Remodeling". Frontiers in Cardiovascular Medicine. 5: 127. doi:10.3389/fcvm.2018.00127. PMC 6141631. PMID 30255026.
8. Lohr JT (1999). "Athletic Heart Syndrome". Gale Encyclopedia of Medicine. Detroit, MI: Gale Research. ISBN 978-0-7876-1868-1.
9. ^ Kindermann W.: Standards der Sportmedizin - Das Sportherz. In: Deutsche Zeitschrift für Sportmedizin. 51, Nr. 9, 2000, S. 307–308,Das Sportherz pdf
10. ^ Rich BS, Havens SA (April 2004). "The athletic heart syndrome". Current Sports Medicine Reports. 3 (2): 84–8. doi:10.1249/00149619-200404000-00006. PMID 14980136.
11. Pelliccia A, Di Paolo FM, Maron BJ (2002). "The athlete's heart: remodeling, electrocardiogram and preparticipation screening". Cardiology in Review. 10 (2): 85–90. doi:10.1097/00045415-200203000-00006. PMID 11895574. S2CID 24094793.
12. Heidbuchel H (September 2018). "The athlete's heart is a proarrhythmic heart, and what that means for clinical decision making". Europace. 20 (9): 1401–1411. doi:10.1093/europace/eux294. PMID 29244075.
13. Brugada J, Benito B. "Electrocardiographic findings in athletes". www.escardio.org. Archived from the original on 5 July 2022. Retrieved 5 July 2022.
14. Drezner JA, Fischbach P, Froelicher V, Marek J, Pelliccia A, Prutkin JM, et al. (February 2013). "Normal electrocardiographic findings: recognising physiological adaptations in athletes". British Journal of Sports Medicine. 47 (3): 125–136. doi:10.1136/bjsports-2012-092068. PMID 23303759. S2CID 8124949.
15. Maron BJ (November 2005). "Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance". Heart. 91 (11): 1380–1382. doi:10.1136/hrt.2005.060962. PMC 1769182. PMID 16230430.
16. Drezner JA, Ashley E, Baggish AL, Börjesson M, Corrado D, Owens DS, et al. (February 2013). "Abnormal electrocardiographic findings in athletes: recognising changes suggestive of cardiomyopathy". British Journal of Sports Medicine. 47 (3): 137–152. doi:10.1136/bjsports-2012-092069. PMID 23303760. S2CID 8534819.
17. Alexander RW, Schlant RC, Fuster V, eds. (1998). The Heart (9th ed.). New York: McGraw-Hill.
18. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, et al. (August 1996). "Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association". Circulation. 94 (4): 850–856. doi:10.1161/01.CIR.94.4.850. PMID 8772711.
19. "Athletic Heart Syndrome". Merck Manual Professional. 2005. Archived from the original on 15 May 2015. Retrieved 30 April 2015.
20. Mountjoy M, Sundgot-Borgen J, Burke L, Carter S, Constantini N, Lebrun C, et al. (April 2014). "The IOC consensus statement: beyond the Female Athlete Triad--Relative Energy Deficiency in Sport (RED-S)". British Journal of Sports Medicine. 48 (7): 491–497. doi:10.1136/bjsports-2014-093502. PMID 24620037.
21. Sachs KV, Harnke B, Mehler PS, Krantz MJ (March 2016). "Cardiovascular complications of anorexia nervosa: A systematic review". The International Journal of Eating Disorders. 49 (3): 238–248. doi:10.1002/eat.22481. PMID 26710932.
22. Kindermann W (2008). "Der Vater des Sportherzens – Herbert Reindell 100 Jahre" (PDF). Deutsche Zeitschrift für Sportmedizin. 59 (3): m 73-75. Archived from the original (PDF) on 3 December 2008.
23. "Chapter 27: Athletic Heart Syndrome". Cardiovascular Medicine. January 2008. Archived from the original on 26 May 2008.
24. Amin, Hina; Siddiqui, Waqas J. (2022), "Cardiomegaly", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 31194436, archived from the original on 16 October 2022, retrieved 3 August 2022
25. De Innocentiis C, Ricci F, Khanji MY, Aung N, Tana C, Verrengia E, et al. (November 2018). "Athlete's Heart: Diagnostic Challenges and Future Perspectives". Sports Medicine. 48 (11): 2463–2477. doi:10.1007/s40279-018-0985-2. PMID 30251086. S2CID 52813585.
26. Rowland T (May 2011). "Is the 'athlete's heart' arrhythmogenic? Implications for sudden cardiac death". Sports Medicine. 41 (5): 401–411. doi:10.2165/11583940-000000000-00000. PMID 21510716. S2CID 11022550.
27. Maron BJ, Pelliccia A (October 2006). "The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death". Circulation. 114 (15): 1633–1644. doi:10.1161/CIRCULATIONAHA.106.613562. PMID 17030703.
28. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F (February 2002). "Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning". Circulation. 105 (8): 944–9. doi:10.1161/hc0802.104534. PMID 11864923. S2CID 8511225.
29. "Athletic Heart Syndrome". The Merck Manuals Online Medical Library. November 2005. Archived from the original on 7 November 2007. Retrieved 24 September 2007.
30. Rost R (August 1997). "The athlete's heart. Historical perspectives--solved and unsolved problems". Cardiology Clinics. 15 (3): 493–512. doi:10.1016/s0733-8651(05)70355-6. PMID 9276172.

External links

• Merck Manual Professional Version

• Heart diseases
• Sports medicine
• Syndromes